← FDA DRUG APPROVALS

FDA NDA · NDA019407

VISINE L.R.

Sponsor: KENVUE BRANDS

APPLICATION
NDA019407
TYPE
NDA
ORIGINAL APPROVAL
1989-03-31
LATEST ACTION
2002-11-01
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Over-the-counter

Products

VISINE L.R. · ReferenceOver-the-counter
OXYMETAZOLINE HYDROCHLORIDE 0.025% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2002-11-01Labeling · Supplement 10 · standardLetterAP
2002-01-11Manufacturing (CMC) · Supplement 9 · standardAP
2000-02-10Manufacturing (CMC) · Supplement 8 · standardAP
1999-10-15Manufacturing (CMC) · Supplement 7 · standardAP
1998-03-17Manufacturing (CMC) · Supplement 6 · standardAP
1998-03-05Manufacturing (CMC) · Supplement 5 · standardAP
1995-08-03Manufacturing (CMC) · Supplement 4 · standardAP
1990-02-13Manufacturing (CMC) · Supplement 2 · standardAP
1989-10-27Labeling · Supplement 1AP
1989-03-31Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →